US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 19.520
  • +0.010+0.05%
Close Oct 15 16:00 ET
  • 19.530
  • +0.010+0.05%
Post 17:19 ET
1.98BMarket Cap-3562P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Development of genome editing-based therapies36.28M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States36.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Gene Editing
Gene Editing
Intraday+0.03%
ARK Portfolio
ARK Portfolio
Intraday-0.22%